Aton Ra Partners Moderna, Inc. Transaction History

Aton Ra Partners

$50.1 Million
Q4 2023

A detailed history of Aton Ra Partners transactions in Moderna, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 2,446 shares of MRNA stock, worth $100,555. This represents 0.48% of its overall portfolio holdings.

Number of Shares

2,446

Previous 2,717 9.97%

Holding current value

$100,555

Previous $280,000 13.21%

% of portfolio

0.48%

Previous 0.59%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$69.51 - $104.43 $18,837 - $28,300	-271 Reduced 9.97%	2,446 $243,000
Q3 2023 Oct 25, 2023	SELL	$96.41 - $126.61 $54,953 - $72,167	-570 Reduced 17.34%	2,717 $280,000
Q2 2023 Jul 18, 2023	SELL	$118.5 - $160.53 $13,983 - $18,942	-118 Reduced 3.47%	3,287 $399,000
Q1 2023 May 05, 2023	SELL	$135.66 - $197.02 $46,260 - $67,183	-341 Reduced 9.1%	3,405 $522,000
Q4 2022 Feb 02, 2023	SELL	$118.38 - $210.04 $119,918 - $212,770	-1,013 Reduced 21.29%	3,746 $672,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $16,765 - $27,573	-142 Reduced 2.9%	4,759 $563,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $510,101 - $769,049	-4,355 Reduced 47.05%	4,901 $700,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $566,793 - $1.05 Million	-4,482 Reduced 32.62%	9,256 $1.59 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $15,581 - $25,427	69 Added 0.5%	13,738 $3.49 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $422,719 - $922,915	-1,905 Reduced 12.23%	13,669 $5.26 Million
Q2 2021 Aug 12, 2021	SELL	$129.91 - $234.98 $1.19 Million - $2.16 Million	-9,180 Reduced 37.08%	15,574 $3.66 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $239,540 - $408,040	2,194 Added 9.73%	24,754 $3.24 Million
Q4 2020 Feb 19, 2021	BUY	$65.74 - $169.86 $1.48 Million - $3.83 Million	22,560 New	22,560 $2.36 Million

Others Institutions Holding MRNA

# of Institutions

952

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.

Account